PBM
Psyence Biomedical Ltd. Common Shares
NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY
$6.59
+29.72% today
Updated 2026-04-30
Market cap
$16.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-389.98
Dividend yield
—
52W range
$2 – $75
Volume
3.0M
Psyence Biomedical Ltd. Common Shares (PBM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-1.40M | $-519603.00 | $-2.95M | $-3.73M |
| Capital expenditures | $0.00 | $0.00 | $5727.00 | $9877.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $332068.00 | $221287.00 | $317882.00 | $0.00 |
| Free cash flow | $-1.40M | $-519603.00 | $-2.95M | $-3.74M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |